Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value: $907M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALDER BIOPHARMACEUTICALS INC | 1,689,071 | $55.35M | 6.1% | $32.02 | — | COM | 014339105 |
| — | NEVRO CORP | 491,044 | $51.26M | 5.7% | $53.99 | — | COM | 64157F103 |
| TBPH | THERAVANCE BIOPHARMA INC | 1,118,372 | $40.53M | 4.5% | $21.59 | +28.9% | COM | G8807B106 |
| — | MINERVA NEUROSCIENCES INC | 2,800,000 | $39.52M | 4.4% | $7.26 | — | COM | 603380106 |
| — | PROTEOSTASIS THERAPEUTICS IN | 2,350,000 | $36.64M | 4.0% | $12.16 | — | COM | 74373B109 |
| — | CLEARSIDE BIOMEDICAL INC | 1,988,208 | $34.5M | 3.8% | $7.01 | — | COM | 185063104 |
| EGRX | EAGLE PHARMACEUTICALS INC | 455,995 | $31.92M | 3.5% | $40.56 | +36.6% | COM | 269796108 |
| HRTX | HERON THERAPEUTICS INC | 1,771,263 | $30.52M | 3.4% | $15.73 | +18.0% | COM | 427746102 |
| ARDX | ARDELYX INC | 2,071,964 | $26.81M | 3.0% | $15.57 | -32.7% | COM | 039697107 |
| — | MYOKARDIA INC | 1,605,790 | $26.24M | 2.9% | $15.55 | — | COM | 62857M105 |
| — | CLOVIS ONCOLOGY INC | 650,000 | $23.43M | 2.6% | $36.05 | — | COM | 189464100 |
| ACRS | ACLARIS THERAPEUTICS INC | 901,286 | $23.08M | 2.5% | $19.47 | +8.9% | COM | 00461U105 |
| — | QUOTIENT LTD | 2,787,717 | $21.8M | 2.4% | $11.34 | — | SHS | G73268107 |
| GLPG | GALAPAGOS NV | 334,044 | $21.44M | 2.4% | $54.92 | — | SPON ADR | 36315X101 |
| MGNX | MACROGENICS INC | 707,978 | $21.18M | 2.3% | $27.09 | +9.8% | COM | 556099109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 398,301 | $20.17M | 2.2% | $15.30 | +225.6% | COM | 64125C109 |
| OMER | OMEROS CORP | 1,695,000 | $18.92M | 2.1% | $15.02 | -24.1% | COM | 682143102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 800,000 | $16.9M | 1.9% | $13.67 | 0.0% | COM | 74366E102 |
| WVE | WAVE LIFE SCIENCES LTD | 507,907 | $16.49M | 1.8% | $17.46 | +35.4% | SHS | Y95308105 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,121,013 | $16.42M | 1.8% | $9.12 | -26.2% | COM NEW | 83587F202 |
| CHRS | COHERUS BIOSCIENCES INC | 576,106 | $15.43M | 1.7% | $20.95 | +30.2% | COM | 19249H103 |
| — | CHINA BIOLOGIC PRODS INC | 112,867 | $14.05M | 1.5% | $67.14 | — | COM | 16938C106 |
| — | CORBUS PHARMACEUTICALS HLDGS | 2,000,000 | $13.58M | 1.5% | $2.99 | — | COM | 21833P103 |
| — | PORTOLA PHARMACEUTICALS INC | 596,000 | $13.54M | 1.5% | $24.54 | — | COM | 737010108 |
| CLLS | CELLECTIS S A | 498,117 | $11.99M | 1.3% | $30.85 | — | SPONSORED ADS | 15117K103 |
| — | AGENUS INC | 1,578,106 | $11.33M | 1.2% | $4.53 | — | COM NEW | 00847G705 |
| — | INVUITY INC | 767,466 | $10.53M | 1.2% | $13.53 | — | COM NEW | 46187J205 |
| — | ADVAXIS INC | 920,915 | $9.845M | 1.1% | $7.66 | — | COM NEW | 007624208 |
| — | GEMPHIRE THERAPEUTICS INC | 900,000 | $9.828M | 1.1% | $10.92 | — | COM | 36870A108 |
| — | CONTRAFECT CORP | 3,840,966 | $9.526M | 1.1% | $2.80 | — | COM | 212326102 |
| — | INC RESH HLDGS INC | 200,000 | $8.916M | 1.0% | $38.13 | — | CL A | 45329R109 |
| — | BLUEPRINT MEDICINES CORP | 298,870 | $8.876M | 1.0% | $26.50 | — | COM | 09627Y109 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 455,515 | $8.773M | 1.0% | $17.28 | -31.3% | COM | 19459J104 |
| DXCM | DEXCOM INC | 100,000 | $8.766M | 1.0% | $7.91 | +181.0% | COM | 252131107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 126,120 | $8.548M | 0.9% | $108.02 | -34.7% | COM | 02043Q107 |
| — | ACHILLION PHARMACEUTICALS | 1,006,128 | $8.15M | 0.9% | $9.29 | — | COM | 00448Q201 |
| — | AUDENTES THERAPEUTICS INC | 449,660 | $8.008M | 0.9% | $17.81 | — | COM | 05070R104 |
| EBS | EMERGENT BIOSOLUTIONS INC | 250,000 | $7.883M | 0.9% | $29.06 | 0.0% | COM | 29089Q105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 110,842 | $7.863M | 0.9% | $51.16 | +24.8% | COM | 90400D108 |
| — | ARRAY BIOPHARMA INC | 1,150,000 | $7.763M | 0.9% | $6.75 | — | COM | 04269X105 |
| FLGT | FULGENT GENETICS INC | 800,000 | $7.376M | 0.8% | $9.20 | 0.0% | COM | 359664109 |
| — | FORWARD PHARMA A/S | 339,175 | $7.123M | 0.8% | $23.76 | — | SPONSORED ADR | 34986J105 |
| SGMO | SANGAMO BIOSCIENCES INC | 1,402,331 | $6.493M | 0.7% | $6.37 | -20.2% | COM | 800677106 |
| — | CURIS INC | 2,410,900 | $6.292M | 0.7% | $2.44 | — | COM | 231269101 |
| — | ZYNERBA PHARMACEUTICALS INC | 480,501 | $6.271M | 0.7% | $13.03 | — | COM | 98986X109 |
| — | RECRO PHARMA INC | 669,239 | $5.916M | 0.7% | $7.16 | — | COM | 75629F109 |
| CTMX | CYTOMX THERAPEUTICS INC | 371,636 | $5.827M | 0.6% | $15.82 | -23.5% | COM | 23284F105 |
| — | DERMIRA INC | 172,083 | $5.82M | 0.6% | $18.24 | — | COM | 24983L104 |
| — | PFENEX INC | 632,559 | $5.661M | 0.6% | $16.67 | — | COM | 717071104 |
| — | AVEXIS INC | 131,858 | $5.434M | 0.6% | $41.21 | — | COM | 05366U100 |
| — | CATABASIS PHARMACEUTICALS IN | 800,000 | $4.928M | 0.5% | $6.16 | — | COM | 14875P107 |
| — | INTEC PHARMA LTD JERUSALEM | 809,804 | $4.762M | 0.5% | $5.59 | — | SHS | M53644106 |
| — | ACCELERON PHARMA INC | 127,451 | $4.612M | 0.5% | $32.04 | — | COM | 00434H108 |
| — | ONCOBIOLOGICS INC | 1,027,216 | $4.366M | 0.5% | $3.40 | — | COM | 68235M105 |
| — | RIGEL PHARMACEUTICALS INC | 1,155,600 | $4.241M | 0.5% | $3.67 | — | COM NEW | 766559603 |
| — | LION BIOTECHNOLOGIES INC | 505,941 | $4.164M | 0.5% | $11.63 | — | COM | 53619R102 |
| — | ATARA BIOTHERAPEUTICS INC | 186,460 | $3.988M | 0.4% | $35.41 | — | COM | 046513107 |
| — | AGILE THERAPEUTICS INC | 563,880 | $3.936M | 0.4% | $7.07 | — | COM | 00847L100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 240,403 | $3.645M | 0.4% | $12.61 | +4.3% | COM | 87164F105 |
| CRVS | CORVUS PHARMACEUTICALS INC | 214,132 | $3.522M | 0.4% | $13.51 | +6.7% | COM | 221015100 |
| — | LIPOCINE INC NEW | 751,296 | $3.351M | 0.4% | $6.47 | — | COM | 53630X104 |
| — | IMMUNE DESIGN CORP | 432,990 | $3.282M | 0.4% | $12.79 | — | COM | 45252L103 |
| — | APTOSE BIOSCIENCES INC | 990,579 | $2.229M | 0.2% | $5.91 | — | COM NEW | 03835T200 |
| RGNX | REGENXBIO INC | 156,741 | $2.196M | 0.2% | $25.52 | -56.8% | COM | 75901B107 |
| — | GLYCOMIMETICS INC | 287,031 | $2.052M | 0.2% | $16.22 | — | COM | 38000Q102 |
| — | AQUINOX PHARMACEUTICALS INC | 151,838 | $2.029M | 0.2% | $12.08 | — | COM | 03842B101 |
| — | CELYAD SA | 75,920 | $1.791M | 0.2% | $51.70 | — | ADR | 151205200 |
| — | EPIZYME INC | 159,513 | $1.57M | 0.2% | $18.78 | — | COM | 29428V104 |
| ASND | ASCENDIS PHARMA A S | 62,254 | $1.251M | 0.1% | $17.30 | — | SPONSORED ADR | 04351P101 |
| FOLD | AMICUS THERAPEUTICS INC | 151,838 | $1.124M | 0.1% | $11.96 | -43.5% | COM | 03152W109 |
| — | AVEO PHARMACEUTICALS INC | 1,087,715 | $968K | 0.1% | $1.74 | — | COM | 053588109 |
| — | NANOSTRING TECHNOLOGIES INC | 40,490 | $809K | 0.1% | $20.55 | — | COM | 63009R109 |
| — | THRESHOLD PHARMACEUTICAL INC | 1,012,255 | $686K | 0.1% | $0.48 | — | COM NEW | 885807206 |
| — | ONCOBIOLOGICS INC | 416,666 | $500K | 0.1% | $0.45 | — | *W EXP 05/18/201 | 68235M121 |
| — | HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $472K | 0.1% | $11.05 | — | COM | 40434H104 |
| — | GENVEC INC | 1,015,685 | $468K | 0.1% | $2.63 | — | COM NEW | 37246C307 |
| — | NEOS THERAPEUTICS INC | 50,613 | $333K | 0.0% | $20.88 | — | COM | 64052L106 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS | 2,226,961 | $221K | 0.0% | $0.81 | -73.1% | COM | 74373P108 |
| — | ONCOBIOLOGICS INC | 416,666 | $199K | 0.0% | $0.46 | — | *W EXP 02/18/201 | 68235M113 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 25,307 | $178K | 0.0% | $18.20 | — | SPONDS ADR | 00653A107 |
| — | APPLIED GENETIC TECHNOL CORP | 17,321 | $169K | 0.0% | $22.99 | — | COM | 03820J100 |
| — | CELLECTAR BIOSCIENCES INC | 53,649 | $145K | 0.0% | $3.40 | — | COM | 15117F302 |
| — | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $114K | 0.0% | $0.22 | — | *W EXP 06/19/202 | 74373P116 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $13,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |